CareLit · DOI-Nachweis · Nuklearmedizin - NuclearMedicine
High sigma-1 receptor (S1R) and very low dopamine 2/dopamine 3 receptor (D2/D3R) occupancy at clinically relevant doses of pridopidine in healthy volunteers (HV) and Huntington disease patients (HD): a F-18-Fluspidine and F-18-Fallypride P…
DOI 10.1055/s-0040-1708168
Bibliografische Angaben
Nachweis in CareLit
Autor:innenPM Meyer, ID Grachev, GA Becker, M Bronzel, D Marsteller, O Voges, L Rabinovich, F Zientek, M Rullmann, B Sattler, M Patt, E Strauss, A Kluge, JM Savola, MF Gordon, M Geva, S Hesse, H Barthel, M Hayden, O Sabri
ZeitschriftNuklearmedizin - NuclearMedicine
Ausgabe02/2020
Jahrgang / SeitenJg. 59
Kernaussage aus der Literatur
Abstract-Vorschau
High sigma-1 receptor (S1R) and very low dopamine 2/dopamine 3 receptor (D2/D3R) occupancy at clinically relevant doses of pridopidine in healthy volunteers (HV) and Huntington disease patients (HD): a F-18-Fluspidine and F-18-Fallypride PET study
Zitieren
Zitierempfehlung
PM Meyer, ID Grachev, GA Becker, M Bronzel, D Marsteller, O Voges, L Rabinovich, F Zientek, M Rullmann, B Sattler, M Patt, E Strauss, A Kluge, JM Savola, MF Gordon, M Geva, S Hesse, H Barthel, M Hayden, O Sabri (2020) High sigma-1 receptor (S1R) and very low dopamine 2/dopamine 3 receptor (D2/D3R) occupancy at clinically relevant doses of pridopidine in healthy volunteers (HV) and Huntington disease patients (HD): a F-18-Fluspidine and F-18-Fallypride PET study. Nuklearmedizin - NuclearMedicine, 59 (02). https://doi.org/10.1055/s-0040-1708168
Mit CareLit weiterarbeiten